Customized drug delivery systems MCQs With Answer

Customized Drug Delivery Systems MCQs With Answer helps M. Pharm students master how therapies are tailored to the patient, disease, and context. This quiz emphasizes science-driven personalization—stimuli-responsive polymers, pharmacogenomic guidance, programmable devices, 3D-printed medicines, and nano-ligand targeting—while linking design choices to clinical performance and regulatory expectations. Questions span release kinetics, materials selection, device algorithms, quality-by-design, and in vitro–in vivo correlation. Each item is crafted to test applied understanding for exams and real-world formulation and device development. Use these MCQs to assess your grasp of how to translate patient variability, site-specific physiology, and therapeutic goals into rational, safe, and effective customized drug delivery solutions.

Q1. In 3D-printed oral dosage forms designed for patient-specific release, which design parameter most directly tunes diffusion pathways and thus the drug release rate?

• Infill density of the printed matrix
• Filament colorant type
• External label ink thickness
• Topcoat pigment concentration

Correct Answer: Infill density of the printed matrix

Q2. For colon-targeted customized delivery in inflammatory bowel disease, which trigger provides the most reliable site-specific activation across patients?

• Gastric residence time exceeding 3 hours
• pH threshold of 7.5 in the terminal ileum
• Biodegradation by colonic azoreductases (azo-bond cleavage)
• Exposure to bile salts in the duodenum

Correct Answer: Biodegradation by colonic azoreductases (azo-bond cleavage)

Q3. Personalizing opioid therapy via customized delivery for codeine hinges on which pharmacogenomic factor?

• CYP2D6 metabolizer status
• VKORC1 haplotype
• SLCO1B1 c.521T>C variant
• UGT1A1*28 genotype

Correct Answer: CYP2D6 metabolizer status

Q4. In dissolving microneedle patches tailored for vaccines, which geometric parameter primarily determines intradermal penetration depth and thus dose deposition?

• Microneedle length
• Array border width
• Backing film color
• Tip base radius of the patch holder

Correct Answer: Microneedle length

Q5. Which oral customized drug delivery platform most closely achieves zero-order release independent of GI pH and motility?

• Elementary osmotic pump tablet with a semipermeable membrane and precision orifice
• Hydrophilic matrix tablet with HPMC K4M
• Enteric-coated monolithic tablet
• Immediate-release capsule with pH modifiers

Correct Answer: Elementary osmotic pump tablet with a semipermeable membrane and precision orifice

Q6. Closed-loop personalized insulin delivery commonly relies on which control strategy to adjust infusion in real time based on glucose sensor input?

• Proportional–integral–derivative (PID) control
• Bang–bang on–off control only
• Fuzzy logic without feedback
• Static scaling factors preset by the user

Correct Answer: Proportional–integral–derivative (PID) control

Q7. To customize stealth behavior of liposomal carriers for oncology patients, which surface modification most effectively reduces opsonization and RES clearance?

• High surface grafting density of PEG 2000 (2–5 mol%)
• Incorporation of cholesterol sulfate only
• Increasing zeta potential to +40 mV
• Adsorption of albumin post-formation without covalent linkage

Correct Answer: High surface grafting density of PEG 2000 (2–5 mol%)

Q8. A nanoparticle intended for customized targeting of HER2-positive tumors should most appropriately display which ligand?

• Trastuzumab-derived single-chain variable fragment (scFv)
• RGD peptide specific for integrin αvβ3 only
• Folate for reduced folate carrier targeting
• Transferrin for BBB transport

Correct Answer: Trastuzumab-derived single-chain variable fragment (scFv)

Q9. Redox-responsive personalized nanocarriers that selectively release cargo in the cytosol of tumor cells most commonly exploit which chemical motif?

• Hydrolytically labile acetal groups
• Disulfide linkages cleaved by intracellular glutathione
• Photo-cleavable o-nitrobenzyl esters
• Thermoresponsive LCST polymers without cleavable bonds

Correct Answer: Disulfide linkages cleaved by intracellular glutathione

Q10. Within a Quality by Design framework for a customized hydrophilic matrix tablet, which critical quality attribute most directly governs diffusional release kinetics?

• Tablet color uniformity
• Matrix porosity and tortuosity
• Embossing depth
• Blister foil thickness

Correct Answer: Matrix porosity and tortuosity

Q11. For individualized pediatric dosing with high acceptability, which solid oral approach is most suitable?

• Large monolithic sustained-release tablets
• 2–3 mm mini-tablets that can be dose-flexibly counted
• Hard gelatin capsules size 00 only
• Powders requiring complex reconstitution steps

Correct Answer: 2–3 mm mini-tablets that can be dose-flexibly counted

Q12. Which 3D printing technique is best suited for manufacturing patient-specific dosage forms containing thermolabile APIs?

• Fused deposition modeling (FDM) at 200–230°C
• Stereolithography (SLA) with high-intensity UV cure
• Binder jetting (powder bed inkjet 3DP) at ambient temperature
• Select laser sintering (SLS) with elevated powder bed temperatures

Correct Answer: Binder jetting (powder bed inkjet 3DP) at ambient temperature

Q13. In a theranostic system enabling personalized, image-guided release, which core enables both MRI visibility and remotely triggered drug liberation?

• Gold nanorods only
• Silica nanoparticles without dopants
• Superparamagnetic iron oxide nanoparticles (SPIONs)
• Calcium phosphate nanoparticles

Correct Answer: Superparamagnetic iron oxide nanoparticles (SPIONs)

Q14. To extend ocular residence time in a patient-specific eye drop while minimizing blur, which in situ gelling strategy is most appropriate?

• Thermoreversible Pluronic F127 gel at 4°C instillation
• Ion-activated gellan gum (gelation by tear cations)
• Highly viscous carbomer gel at 2% w/w
• Immediate-release aqueous solution without polymers

Correct Answer: Ion-activated gellan gum (gelation by tear cations)

Q15. For customized buccal delivery of a peptide where first-pass avoidance is critical, which permeation enhancer is most appropriate?

• Sodium glycocholate
• Menthol flavoring agent
• Propylene glycol humectant
• Polyethylene glycol 400 plasticizer

Correct Answer: Sodium glycocholate

Q16. A personalized drug–device transdermal patch is a combination product. Which US regulation specifically addresses cGMP requirements for such combination products?

• 21 CFR Part 210 only
• 21 CFR Part 820 only
• 21 CFR Part 11
• 21 CFR Part 4

Correct Answer: 21 CFR Part 4

Q17. When customizing release profiles and leveraging IVIVC for biopredictive control, which IVIVC level offers the strongest, point-to-point relationship?

• Level C
• Level B
• Level A
• Multiple Level C

Correct Answer: Level A

Q18. Individualizing dosing using therapeutic drug monitoring is optimally supported by which Bayesian approach?

• Non-compartmental analysis with trough-only rules of thumb
• Fixed dose nomograms without patient covariates
• Maximum a posteriori Bayesian estimation using population PK models
• Visual curve fitting by manual trial-and-error

Correct Answer: Maximum a posteriori Bayesian estimation using population PK models

Q19. To reduce the risk of dose dumping due to variable gastric emptying in personalized gastro-resistant therapy, which platform is preferred?

• Single enteric-coated monolithic tablet
• Enteric-coated multiparticulate pellets filled in capsules
• Uncoated IR tablet co-administered with antacids
• Chewable enteric tablet

Correct Answer: Enteric-coated multiparticulate pellets filled in capsules

Q20. For a patient-specific, water-containing oral suspension compounded extemporaneously, what is the recommended beyond-use date under USP <795> when refrigerated?

• 72 hours
• 7 days
• 14 days
• 30 days

Correct Answer: 14 days

Download